Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3025% below fair value
$1.94+0.04 (+2.11%)
Close on Nov 18, 2026Market cap $390.96MP/E –Yield –
Cerus free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cerus's free cash flow for the twelve months ending Sep 30, 2026 was $494.00K, up 194.0% year over year. For fiscal 2025 it was $1.11M, down 87.0% from the year before. The highest annual figure on record is $8.52M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11M | -87.0% |
| FY2024 | Dec 31, 2024 | $8.52M | – |
| FY2023 | Dec 31, 2023 | -$47.77M | – |
| FY2022 | Dec 31, 2022 | -$27.62M | – |
| FY2021 | Dec 31, 2021 | -$34.83M | – |
| FY2020 | Dec 31, 2020 | -$43.43M | – |
| FY2019 | Dec 31, 2019 | -$74.43M | – |
| FY2018 | Dec 31, 2018 | -$32.39M | – |
| FY2017 | Dec 31, 2017 | -$52.59M | – |
| FY2016 | Dec 31, 2016 | -$54.09M | – |
| FY2015 | Dec 31, 2015 | -$51.85M | – |
| FY2014 | Dec 31, 2014 | -$41.92M | – |
| FY2013 | Dec 31, 2013 | -$27.33M | – |
| FY2012 | Dec 31, 2012 | -$14.00M | – |
| FY2011 | Dec 31, 2011 | -$15.79M | – |
| FY2010 | Dec 31, 2010 | -$15.96M | – |
| FY2009 | Dec 31, 2009 | -$14.74M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.42M | +2471.3% |
| Q2 FY2026 | Jun 30, 2026 | -$3.53M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.28M | – |
| Q4 FY2025 | Dec 31, 2025 | $4.89M | +23.8% |
| Q3 FY2025 | Sep 30, 2025 | $94.00K | -97.2% |
| Q2 FY2025 | Jun 30, 2025 | -$2.92M | -911.9% |
| Q1 FY2025 | Mar 31, 2025 | -$956.00K | -211.2% |
| Q4 FY2024 | Dec 31, 2024 | $3.95M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.35M | – |
| Q2 FY2024 | Jun 30, 2024 | $360.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $860.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$15.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.12M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.44M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.02M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.99M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.63M | – |
| Q2 FY2022 | Jun 30, 2022 | -$423.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$21.57M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.69M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.70M | – |
| Q1 FY2021 | Mar 31, 2021 | -$17.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.37M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.43M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.37M | – |
| Q1 FY2020 | Mar 31, 2020 | -$20.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.70M | – |
| Q3 FY2019 | Sep 30, 2019 | -$24.16M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.08M | – |
| Q1 FY2019 | Mar 31, 2019 | -$25.49M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.62M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.38M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.38M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.03M | – |
| Q3 FY2017 | Sep 30, 2017 | -$12.85M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.17M | – |
| Q1 FY2017 | Mar 31, 2017 | -$16.53M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.92M | – |
See a number that looks wrong?